Patent · US Active

Polynucleotide molecules used for the prevention or treatment of HPV infection related diseases

US12318441B2 · kind B2 · utility

0Cited by

0References

25Claims

0Family size

Assignees

RINUAGENE BIOTECHNOLOGY CO. LTD. · CN
RINUAGENE INTERNATIONAL HK LIMITED · CN

Inventors

Shan Cen · Beijing, CN
Jing Wang · Taipei, TW
Weiguo Zhang · Tangxia, CN
Yijie Dong · Suzhou, CN

Key dates

Filing date	Jul 11, 2024
Grant date	Jun 3, 2025
Priority date	—
Expiry date	Jul 11, 2044

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2710/20034
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to a polynucleotide molecule that can be used for preventing or treatment HPV infection-related diseases, and a pharmaceutical product, a pharmaceutical composition, or an mRNA vaccine comprising said polynucleotide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.